We are live on ! Find out more
RGLS

Regulus Therapeutics

Delisted

RGLS was delisted on the 24th of June, 2025.

27 hedge funds and large institutions have $11.3M invested in Regulus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more capital invested

Capital invested by funds: $2.71M → $11.3M (+$8.62M)

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

1.94% more ownership

Funds ownership: 2.47%4.41% (+1.9%)

4% less funds holding

Funds holding: 2827 (-1)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
5
Reduced
7
Closed
7
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
+$12K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
-$2.16K -188 -95%
Group One Trading
27
Group One Trading
Illinois
-$2K -160 Closed
TRCT
28
Tower Research Capital (TRC)
New York
-$1.09K -95 -83%
WAM
29
Wealthspire Advisors (Maryland)
Maryland
-$1K -73 Closed
JP Morgan Chase
30
JP Morgan Chase
New York
+$81 +7 New
SPIA
31
Steward Partners Investment Advisory
New York
+$92 +8 New